Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT06644183 · RECRUITING
Trial details
- NCT number
- NCT06644183
- Sponsor
- Jennifer R. Brown, MD, PhD
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-19
- Primary completion
- 2028-10-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.